Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 May, 2018 18:12 IST
Indoco Remedies gets 8 USFDA observations for its Goa unit
Source: IRIS | 14 Feb, 2018, 10.09AM
Comments  |  Post Comment

Indoco Remedies has informed that USFDA inspected its solid dosage plant in Goa (Unit I). At the end of the inspection, the plant has received 8 observations (483s). The filling indicates that all the observations are correctable and the company is in the process of preparing its response for the same.

Exports from Goa solid dosage plant constitute less than 10% of the Indoco’s total exports and less than 4% of the total sales.

Shares of the company declined Rs 6.45, or 2.33%, to trade at Rs 269.90. The total volume of shares traded was 7,323 at the BSE (9.59 a.m., Wednesday).





Indoco Remedies Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Sun Pharmaceutical Industries quarterly earnings up 7% - 25-May-2018 16:12
Tech Mahindra quarterly profit zooms 2.09 times to Rs 12.31 bn - 25-May-2018 16:02
Lupin submits MAA for Etanercept Biosimilar in Europe - 25-May-2018 12:35
HDFC Sec maintains 'Buy' on Granules India - 25-May-2018 11:37
Zydus Cadila gets USFDA nod for Dutasteride, Tamsulosin HCl capsules - 25-May-2018 11:05
Pidilite Industries quarterly earnings surge 57.43% - 25-May-2018 10:34
United Breweries quarterly earnings soar 13.51 times - 25-May-2018 10:23
Larsen & Tubro bags order worth Rs 31.91 bn - 25-May-2018 09:57
MCX strengthens precious metals suite with launch of silver options - 24-May-2018 17:54
Granules India quarterly earnings plummet 55% - 24-May-2018 17:04
GAIL (India) quarterly profit zooms 3.92 times - 24-May-2018 16:58
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer